Swedish website
Listen

The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here: https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.

Breast and Ovarian Cancer Genomics

Faculty of Medicine / Department of Clinical Sciences, Lund / Section I / Breast/ovarian cancer
Breast and Ovarian Cancer Genomics' profile in Lund University Research portal

Description

Breast and ovarian cancers are complex and heterogeneous, and share several features, including genetic predisposition caused by BRCA1/2 mutations. Ovarian cancer is however associated with poor survival relative to breast cancer. Utilizing comprehensive biobanks, high-throughput omics methods and in vitro model systems we aim to advance our understanding of tumour evolution, disease heterogeneity and therapy response, thereby improving our knowledge of the origin and genomic events leading to the development of breast/ovarian cancer. Deeper understanding of key processes involved in tumour initiation, development and maintenance may be translated to precision treatment. Identification of novel therapeutic targets, stratified by histological as well as molecular phenotypes, should transform survival prospects. Improved knowledge of the spatiotemporal molecular landscapes of these malignancies may lead to the development of biologically informed treatment strategies and clinical trials.

Coworkers

E

  • Anna Ebbesson

    Research project participant

    anna [dot] ebbesson [at] med [dot] lu [dot] se

H

J

M

T

  • Lena Tran

    Research project participant

    lena [dot] tran [at] med [dot] lu [dot] se

V

  • Srinivas Veerla

    Research project participant

    srinivas [dot] veerla [at] med [dot] lu [dot] se

W